Book Demo

Thrivable white paper

How geography and urbanicity are shaping the GLP-1 landscape

Learn why, despite consistent provider conversations across regions, our data suggests differences emerge when it comes to patients starting and continuing GLP-1 therapy.

 

What you get

  • A detailed report consisting of insights from 1,000+ GLP-1 eligible adults and 130 healthcare providers.

  • A breakdown of directional patterns across geography and urbanicity, highlighting where support can drive disproportionate impact.

  • A guide to the better path: Understand where this drop-off occurs, and why it is essential for improving access, supporting clinicians, and meeting patients where they are.

T R U S T E D    B Y :

Medtronic logo dark blue 600x219
tandem logo -new
American Diabetes Association ADA logo png
y-prime-logo-rgb-color
diabeloop logo
emvenio_logo_color

Ready to level up your next GLP-1 commercial strategy? 

This white paper explores directional patterns and their implications for commercial and brand teams working to expand GLP-1 access where it can have the greatest impact.

people illustration 17

"Having quick and easy access to our target audience has provided us a powerful tool for the business, allowing us to shorten the cycle for testing, making revisions, and re-testing."

John C.
Sr. Marketing Research Manager
 
logo for slider

 

Want What if Understanding Your Target Patient Population Weren’t a Struggle? learn more about how Thrivable can make it easier for you to help you better understand transform your patient research efforts?